Decibel Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Decibel Therapeutics

14/05/2022 24:37

* Decibel Therapeutics Inc  DBTX.OQ  reported a quarterly
adjusted
loss of 56 cents​​ per share for the quarter ended in March. The
mean expectation of six analysts for the quarter was for a loss
of 56 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Decibel Therapeutics Inc's reported EPS for the quarter
was a
loss of 56 cents​.
    * The mean earnings estimate of analysts had risen by
about 4.4%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Decibel Therapeutics Inc shares had fallen by 31.9% this
quarter and lost 55.5% so far this year.
    * The company reported a quarterly loss of $14.02 million.
    * Wall Street's median 12-month price target for Decibel
Therapeutics Inc is $18.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated May 13 at 11:36 p.m.  ​All
figures in US dollars unless otherwise stated